MYSORPETRO vs SUDARSHAN: Stock Comparison
MYSORPETRO shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
MYSORPETRO leads 2; SUDARSHAN leads 2 of 7
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | MYSORPETRO | SUDARSHAN |
|---|---|---|
| Live Price | ₹153.53 | ₹32.71 |
| Day Change | -7.57% | 0.03% |
| Volume | 49,408 | 92,985 |
| 52-Week High | ₹182.03 | ₹39.3 |
| 52-Week Low | ₹111 | ₹31.01 |
| Distance from 52W High | -15.66% | -16.77% |
Valuation
| Metric | MYSORPETRO | SUDARSHAN |
|---|---|---|
| Market Cap | ₹83 Cr | ₹0 Cr |
| P/E Ratio | — | 28.27x |
| P/B Ratio | — | 4.11x |
| EPS | ₹13.68 | ₹0.32 |
| Book Value | ₹341.53 | ₹6.14 |
| Dividend Yield | 1.59% | 0% |
Growth
| Metric | MYSORPETRO | SUDARSHAN |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | -17.82% | 24.4% |
| Qtr Profit Growth | -5.81% | 38.7% |
Profitability & Leverage
| Metric | MYSORPETRO | SUDARSHAN |
|---|---|---|
| Net Margin | 0% | 0% |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | MYSORPETRO | SUDARSHAN |
|---|---|---|
| Promoter Holding | 72.99% | 57.81%▼ 1.12 pp |
| FII Holding | 3.03% | 21.95%▲ 2.57 pp |
| DII Holding | 0.44% | 0% |
| Public Holding | 23.54% | 20.19%▼ 1.45 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MYSORPETRO and SUDARSHAN PHARMA IND.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.

